Ann: Avexa exits CSIRO's AGPP arrangement , page-8

I see this as sound management - They are happy with the R&D, want to keep the IP and confident about their ability to fund moving forward.

Anyone who thinks this was bad news is confused.

And Peter, remember AVX used Tibotec fo at their cost for much of the Integrase R&D and kept the IP so not the first time

All good news, those who continue to negatively attack management just need to be patient.